232 related articles for article (PubMed ID: 19479828)
1. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
[TBL] [Abstract][Full Text] [Related]
2. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension.
Cardillo C; Campia U; Kilcoyne CM; Bryant MB; Panza JA
Circulation; 2002 Jan; 105(4):452-6. PubMed ID: 11815427
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men.
Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA
Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196
[TBL] [Abstract][Full Text] [Related]
4. Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome.
Schinzari F; Iantorno M; Campia U; Mores N; Rovella V; Tesauro M; Di Daniele N; Cardillo C
Am J Physiol Endocrinol Metab; 2015 Nov; 309(9):E787-92. PubMed ID: 26374766
[TBL] [Abstract][Full Text] [Related]
5. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
Oechslin E; Kiowski W; Schindler R; Bernheim A; Julius B; Brunner-La Rocca HP
Circulation; 2005 Aug; 112(8):1106-12. PubMed ID: 16103236
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
Böhm F; Ahlborg G; Pernow J
Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men.
Brar V; Gill S; Cardillo C; Tesauro M; Panza JA; Campia U
PLoS One; 2015; 10(3):e0121810. PubMed ID: 25807234
[TBL] [Abstract][Full Text] [Related]
8. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Circ Res; 2001 Nov; 89(11):969-76. PubMed ID: 11717152
[TBL] [Abstract][Full Text] [Related]
9. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor blockade improves endothelial function in human internal mammary arteries.
Verma S; Lovren F; Dumont AS; Mather KJ; Maitland A; Kieser TM; Kidd W; McNeill JH; Stewart DJ; Triggle CR; Anderson TJ
Cardiovasc Res; 2001 Jan; 49(1):146-51. PubMed ID: 11121806
[TBL] [Abstract][Full Text] [Related]
11. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.
Böhm F; Beltran E; Pernow J
J Intern Med; 2005 Mar; 257(3):263-71. PubMed ID: 15715683
[TBL] [Abstract][Full Text] [Related]
13. Enhanced endothelin-1 system activity with overweight and obesity.
Weil BR; Westby CM; Van Guilder GP; Greiner JJ; Stauffer BL; DeSouza CA
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H689-95. PubMed ID: 21666117
[TBL] [Abstract][Full Text] [Related]
14. Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity.
Schinzari F; Tesauro M; Veneziani A; Mores N; Di Daniele N; Cardillo C
Hypertension; 2018 Jan; 71(1):185-191. PubMed ID: 29203627
[TBL] [Abstract][Full Text] [Related]
15. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Di Daniele N; Mores N; Veneziani A; Cardillo C
J Clin Endocrinol Metab; 2013 Mar; 98(3):1235-41. PubMed ID: 23372172
[TBL] [Abstract][Full Text] [Related]
16. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
17. A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury.
Thijssen DH; Ellenkamp R; Kooijman M; Pickkers P; Rongen GA; Hopman MT; Smits P
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):325-31. PubMed ID: 17122448
[TBL] [Abstract][Full Text] [Related]
18. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity.
Schinzari F; Veneziani A; Mores N; Barini A; Di Daniele N; Cardillo C; Tesauro M
Hypertension; 2017 May; 69(5):942-949. PubMed ID: 28289180
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits.
Dumont AS; Lovren F; McNeill JH; Sutherland GR; Triggle CR; Anderson TJ; Verma S
J Neurosurg; 2001 Feb; 94(2):281-6. PubMed ID: 11213966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
